A Cost-effectiveness Analysis of Ferric Carboxymaltose in Patients With Iron Deficiency and Chronic Heart Failure in Spain;Evaluación económica de la utilización de hierro carboximaltosa en pacientes con deficiencia de hierro e insuficiencia cardiaca crónica en España

Revista Espanola de Cardiologia

Volumn 68, Issue 10, 2015, Pages 846-851

  Comín Colet, Josep ^a,b   Rubio Rodríguez, Darío ^c   Rubio Terrés, Carlos ^c   Enjuanes Grau, Cristina ^a,b   Gutzwiller, Florian S ^d   Anker, Stefan D ^e   Ponikowski, Piotr ^f  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Health Value   (Spain)

^d UNIVERSITY OF BASEL   (Switzerland)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Anemia; Cost effectiveness analysis; Ferric carboxymaltose; Heart failure; Iron deficiency

Indexed keywords

FERRIC CARBOXYMALTOSE; FERRIC ION; MALTOSE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE; HEART FAILURE; HUMAN; IRON DEFICIENCY; QUALITY ADJUSTED LIFE YEAR; SPAIN; AGED; ANALOGS AND DERIVATIVES; ANEMIA, IRON-DEFICIENCY; COMPLICATION; COST BENEFIT ANALYSIS; DRUG COST; ECONOMICS; FEMALE; FOLLOW UP; INCIDENCE; MALE;

AGED; ANEMIA, IRON-DEFICIENCY; COST-BENEFIT ANALYSIS; DRUG COSTS; FEMALE; FERRIC COMPOUNDS; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INCIDENCE; MALE; MALTOSE; SPAIN;

EID: 85016489366     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2014.10.011     Document Type: Article

References (23)

1. M. Anguita Sánchez, M.G. Crespo Leiro, E. De Teresa Galván, M. Jiménez Navarro, L. Alonso-Pulpón, J. Muñiz García en representación de los investigadores del estudio PRICE Prevalencia de la insuficiencia cardiaca en la población general española mayor de 45 años. Estudio PRICE Rev Esp Cardiol. 61 2008 1041 1049
2. I. Sayago-Silva, F. García-López, and J. Segovia-Cubero Epidemiología de la insuficiencia cardiaca en España en los últimos 20 años Rev Esp Cardiol. 66 2013 649 656
3. J. Comin-Colet, C. Enjuanes, G. González, A. Torrens, M. Cladellas, O. Meroño, and et al. Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status Eur J Heart Fail. 15 2013 1164 1172
4. E.A. Jankowska, P. Rozentryt, A. Witkowska, J. Nowak, O. Hartmann, B. Ponikowska, and et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure Eur Heart J. 31 2010 1872 1880
5. I.T. Klip, J. Comin-Colet, A.A. Voors, P. Ponikowski, C. Enjuanes, W. Banasiak, and et al. Iron deficiency in chronic heart failure: an international pooled analysis Am Heart J. 165 2013 575 582
6. D.S. Silverberg, D. Wexler, M. Blum, Y. Wollman, D. Schwartz, D. Sheps, and et al. The interaction between heart failure, renal failure and anemia - the cardio-renal anemia syndrome Blood Purif. 22 2004 277 284
7. E.A. Jankowska, P. Rozentryt, A. Witkowska, J. Nowak, O. Hartmann, B. Ponikowska, and et al. Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure J Card Fail. 17 2011 899 906
8. S.D. Anker, J. Comin Colet, G. Filippatos, R. Willenheimer, K. Dickstein, H. Drexler, and et al. FAIR-HF committees and investigators. Rationale and design of Ferinject® Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia Eur J Heart Fail. 11 2009 1084 1091
9. C. Berry, D.R. Murdoch, and J.J. McMurray Economics of chronic heart failure Eur J Heart Fail. 3 2001 283 291
10. C. Rubio Terrés Métodos para la realización de evaluaciones económicas de intervenciones sanitarias GH Continuada. 5 2006 302 306
11. F.S. Gutzwiller, M. Schwenkglenks, P.R. Blank, P. Braunhofer, C. Mori, T.D. Szucs, and et al. Health economic assessment of ferric carboxymaltose in patients with iron deficiency and chronic heart failure based on the FAIR-HF trial: an analysis for the UK Eur J Heart Fail. 14 2012 782 790
12. S.D. Anker, J. Comin Colet, G. Filippatos, R. Willenheimer, K. Dickstein, H. Drexler, et al. FAIR-HF Trial Investigators Ferric carboxymaltose in patients with heart failure iron deficiency N Engl J Med. 361 2009 2436 2448
13. Norma Estatal de los GRD (AP-GRD V25) por grupos de hospitales (cluster). Año 2010 [citado 24 May 2013]. Disponible en: http://www.msssi.gob.es/estadEstudios/estadisticas/docs/NormaGRD2010/NORMA-2010-AP-GRD-V25-CLUSTER.pdf
14. X. Calvet, M.A. Ruiz, A. Dosal, L. Moreno, M. López, A. Figuerola, and et al. Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose for the ambulatory treatment of severe iron deficiency PLoS One. 7 2012 e45604
15. Bot Plus 2.0. Consejo General de Colegios Oficiales de Farmacéuticos [citado 24 May 2013]. Disponible en: https://botplusweb.portalfarma.com/
16. J.A. Sacristán, J. Oliva, J. Del Llano, L. Prieto, and J.L. Pinto ¿Qué es una tecnología sanitaria eficiente en España? Gac Sanit. 16 2002 334 343
17. T. Smith, L. Jordaens, D.A. Theuns, P.F. Van Dessel, A.A. Wilde, and M.G. Hunink The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis Eur Heart J. 34 2013 211 219
18. D. Callejo, M. Guerra, A. Hernández-Madrid, and J.A. Blasco Evaluación económica de la terapia de resincronización cardiaca Rev Esp Cardiol. 63 2010 1235 1243
19. C. Rubio-Terrés, J.A. Sacristán, X. Badía, E. Cobo, F. García Alonso Grupo ECOMED Métodos utilizados para realizar evaluaciones económicas de intervenciones sanitarias Med Clin (Barc). 122 2004 578 583
20. P. Ponikowski, D.J. Van Veldhuisen, J. Comin-Colet, G. Ertl, M. Komajda, V. Mareev, and et al. Rationale and design of the CONFIRM-HF study: a double-blind, randomized, placebo-controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency ESC Heart Failure. 1 2014 52 58
21. P. Ponikowski, D.J. Van Veldhuisen, J. Comin-Colet, G. Ertl, M. Komajda, V. Mareev, et al. CONFIRM-HF Investigators Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency Eur Heart J. 2014 10.1093/eurheartj/ehu385
22. C. Rubio-Terrés, E. Cobo, J.A. Sacristán, L. Prieto, J. Del Llano, X. Badía Grupo ECOMED Análisis de la incertidumbre en las evaluaciones económicas de intervenciones sanitarias Med Clin (Barc). 122 2004 668 674
23. J. Comin-Colet, M. Lainscak, K. Dickstein, G.S. Filippatos, P. Johnson, T.F. Lüscher, and et al. The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study Eur Heart J. 34 2012 30 38